The present study addressed the role of N-linked glycosylation of the human dopamine transporter (DAT) in its function with the help of mutants, in which canonical N-glycosylation sites have been removed (N181Q, N181Q,N188Q, and N181Q,N188Q,N205Q), expressed in human embryonic kidney-293 cells. Removal of canonical sites produced lower molecular weight species as did enzymatic deglycosylation or blockade of glycosylation, and all three canonical sites were found to carry sugars. Prevention of N-glycosylation reduced both surface and intracellular DAT. Although partially or non-glycosylated DAT was somewhat less represented at the surface, no evidence was found for preferential exclusion of such material from the plasma membrane, indicating that glycosylation is not essential for DAT expression. Non-glycosylated DAT was less stable at the surface as revealed by apparently enhanced endocytosis, consonant with weaker DAT immunofluorescence at the cell surface and stronger presence in cytosol in confocal analysis of the double and triple mutant. Non-glycosylated DAT did not transport dopamine as efficiently as wild-type DAT as judged from the sharp reduction in uptake V max , and prevention of N-glycosylation enhanced the potency of cocaine-like drugs in inhibiting dopamine uptake into intact cells without changing their affinity for DAT when measured in membrane preparations prepared from these cells. Thus, non-glycosylated DAT at the cell surface displays appreciably reduced catalytic activity and altered inhibitor sensitivity compared with wild type.Biogenic amine carriers include the dopamine transporter (DAT), 1 the norepinephrine transporter, and the serotonin transporter, all part of the larger family of Na ϩ ,Cl Ϫ -dependent neurotransmitter transporters (1), which also includes the nonbiogenic amine subfamily of ␥-aminobutyric acid-related transporters (2). In the brain, the DAT is responsible for the clearance of extraneuronal dopamine thought to be the crucial process for terminating dopamine action (3). The DAT is a heavily glycosylated protein with sugars attached to asparagine (4 -6). In general, carbohydrate units of glycoproteins can play several roles, such as controlling protein folding, stabilizing protein conformation, protecting against proteolysis, and regulating intracellular and surface trafficking (7). Early on, for the DAT, glycosylation has been proposed to alter uptake function (6); thus, the generally higher K m values for dopamine uptake in cell systems (micromolar) as compared with striatal synaptosomes (submicromolar) is speculated to be due to environment-specific differences in glycosylation, both in extent and type of sugars.So far, only limited information is available to answer the question as to whether or how glycosylation affects DAT function. In a preliminary report, we describe the generation of three N-glycosylation mutants in which the three putative N-linked glycosylation sites in human DAT are removed: the single mutant N181Q, the double mutant N181Q,N188Q, and the tripl...